Notis
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
Bio-Works Technologies har mottagit en order värd 5,5...
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
Episurf improves results and focuses on the US
Dynavox Group acquires RehaMedia for EUR 5,8 million
ProstaLund applies for delisting
XVIVO reports negative growth for Q2
AbbVie pays $700 million for multispecific antibody
Arjo reports 3 percent organic growth
iZafe takes the next step in the Nordics – begins Finnish partnership for Dosell
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
Episurf improves results and focuses on the US
Dynavox Group acquires RehaMedia for EUR 5,8 million
NEWSLETTER
Upcoming events
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
Recommended
Trump threatens 200 percent tariffs on pharmaceuticals
AbbVie acquires Capstan Therapeutics for up to $2,1 billion
GLP-1 drugs drive pharmaceutical boom to 2030
FDA introduces fast track for drugs of national importance
Monetization of future royalties increasingly popular
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Today's news roundup
